Arbovirus Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Canada - Size and Forecast 2024-2028

Arbovirus Testing Market Size 2024-2028 

The arbovirus testing market size is forecast to increase by USD 250.1 million and is estimated to grow at a CAGR of 4.5% between 2023 and 2028. The healthcare industry is experiencing significant growth due to the increasing prevalence of viral infections and the subsequent demand for diagnostic services. In response, there has been a surge in the number of diagnostic laboratories, providing advanced testing solutions to identify and treat various diseases. Furthermore, the investment in healthcare infrastructure has been on the rise, leading to the establishment of modern hospitals and clinics equipped with state-of-the-art technology. This trend is expected to continue, as the importance of early and accurate diagnosis becomes increasingly recognized. The growth of diagnostic laboratories and healthcare infrastructure is a positive development, ensuring better health outcomes for individuals and communities.

What will be the Size of the Market During the Forecast Period?

For More Highlights About this Report, Request Free Sample

Market Dynamic and Customer Landscape

Arboviruses are infectious diseases transmitted by arthropods, primarily mosquitoes and ticks. Neglected tropical diseases, including Dengue, Chikungunya, Encephalitis caused by the Powassan virus, and infections from Zika, West Nile fever, among others, pose significant public health challenges. Diagnostic tests play a crucial role in patient management, public health interventions, surveillance, outbreak response, and disease prevention strategies. Lateral flow assays, Next-generation sequencing, RT PCR tests, and ELISA tests are commonly used for arbovirus detection. Hospitals, diagnostic centers, and public health laboratories are major end-users of these In-Vitro Diagnostic (IVD) tests. The market for arbovirus testing is expected to grow due to the increasing burden of these diseases, advancements in diagnostic technologies, and the need for early and accurate diagnosis. Mosquito-borne diseases, such as Dengue and Chikungunya, are prevalent in tropical and subtropical regions, driving the demand for arbovirus testing. The market is also influenced by factors like government initiatives for disease surveillance and control programs. The use of advanced technologies like next-generation sequencing and real-time PCR in arbovirus testing is expected to propel market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Growing cases of viral infections is notably driving market growth. The global market is experiencing significant growth due to the increasing prevalence and diagnosis of arbovirus infections, particularly dengue haemorrhagic fever and dengue shock syndrome. Viral diseases, such as these, pose a significant burden on public health and healthcare spending. Despite the availability of approved drugs, the need for effective testing remains crucial for prevention and control measures.

Moreover, the geriatric population is also at a higher risk of contracting arbovirus infections, making comprehensive surveillance programs and integrated response strategies essential. Thus, such factors are driving the growth of the market during the forecast period.

Significant Market Trends

Use of digital healthcare techniques in rapid diagnostics is the key trend in the market. The market has gained significant importance in the public health sector due to the increasing prevalence of viral diseases such as dengue haemorrhagic fever and dengue shock syndrome. Prevention and control measures for these diseases require comprehensive surveillance programs and integrated response strategies.

Moreover, digital health technologies have emerged as an effective tool in this regard, enabling rapid diagnostics and remote health monitoring. The geriatric population is particularly vulnerable to these diseases, making early and accurate diagnosis crucial. Laboratory networks play a vital role in the testing process, ensuring standardized procedures and test accuracy. Thus, such trends will shape the growth of the market during the forecast period.

Major Market Challenge

The high cost of rapid diagnostic products is the major challenge that affects the growth of the market. Arboviruses, including those causing dengue haemorrhagic fever and dengue shock syndrome, pose a significant threat to public health worldwide. Effective prevention and control measures are crucial to mitigate the impact of these viral diseases, particularly in vulnerable populations such as the geriatric demographic.

However, the lack of standardization in arbovirus testing services is a major challenge for public health laboratories in ensuring adequate capacity and capabilities to address endemic and epidemic outbreaks. The utilization of advanced testing equipment for diagnosis contributes to increased healthcare spending. Hence, the above factors will impede the growth of the market during the forecast period.

Exculsive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories: The company offers arbovirus testing solutions that help enable earlier diagnosis, appropriate therapy selection, personalized care, and infectious disease monitoring.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AESKU.GROUP GmbH and Co. KG
• Agilent Technologies Inc.
• ARUP Laboratories
• Bio Rad Laboratories Inc.
• BioAgilytix Labs
• Copley Scientific Ltd.
• DiaSorin SpA
• Distek Inc.
• Fluke Biomedical
• Laboratory Corp. of America Holdings
• Mayo Foundation for Medical Education and Research
• Merck KGaA
• NovaTec Immundiagnostica GmbH
• Perkin Elmer Inc.
• Response Biomedical Corp.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

By End-user 

The diagnostic laboratories segment is estimated to witness significant growth during the forecast period. Arboviruses, transmitted by arthropods such as mosquitoes and ticks, are a significant cause of Neglected Tropical Diseases (NTDs), including Dengue, Chikungunya, Encephalitis, Zika, and Yellow fever virus infections. Hospitals, diagnostic centers, public health laboratories, and research institutions employ various diagnostic tests to manage patients and implement public health interventions.

Get a glance at the market share of various regions Download the PDF Sample

The diagnostic laboratories segment was the largest segment and valued at USD 477.80 million in 2018. Lateral flow assays, Next-generation sequencing, RT-PCR tests, and ELISA tests are commonly used for arbovirus detection. Arthropod-borne viruses like Yellow fever, Powassan, and diagnostic tests for dengue fever, Zika virus infection, West Nile fever, and other diseases are crucial for risk monitoring, detection, and response. Molecular diagnostics and serological assays enable pandemic prevention and disease surveillance. Hence, such factors are fuelling the growth of this segment during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Arboviruses, transmitted by arthropods such as mosquitoes and ticks, are a significant cause of Neglected Tropical Diseases (NTDs), including Dengue, Chikungunya, Encephalitis, Zika, and Yellow fever virus infections. Diagnostic tests play a crucial role in patient management, public health interventions, surveillance, outbreak response, and disease prevention strategies. Hospitals, diagnostic centers, public health laboratories, and research institutions employ various diagnostic tools, such as Lateral flow assays, Next-generation sequencing, RT-PCR tests, and ELISA tests, for arbovirus detection. Hence, such factors are driving the market in North America during the forecast period.

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• End-user Outlook
  • Diagnostic laboratories
  • Hospitals
  • Research centers
  • Others
• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

You may also interested in below market reports:

• Human Immunodeficiency Virus Rapid Test Kits Market: Human Immunodeficiency Virus Rapid Test Kits Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast
• Zika Virus Therapeutics Market: Zika Virus Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Denmark, China, Canada, India - Size and Forecast
• Japanese Encephalitis Vaccines (JEV) Market: Japanese Encephalitis Vaccines (JEV) Market Analysis Asia, Rest of World (ROW), Europe, North America - South Korea, Australia, China, India, Japan - Size and Forecast

Market Analyst Overview

Arboviruses, transmitted by arthropods such as mosquitoes and ticks, cause a range of Neglected Tropical Diseases (NTDs) including Dengue, Chikungunya, Encephalitis, Zika, and Yellow fever virus. The Market is witnessing significant growth due to the increasing incidence of these diseases and the need for accurate and timely diagnosis. Lateral flow assays, Next-generation sequencing, RT PCR tests, and ELISA tests are the most common diagnostic methods used for arbovirus detection. Hospitals, Diagnostic centers, Public health laboratories, and Research centers are the major end-users of these tests. IVD companies, Diagnostic Laboratories, and Research Institutions are the key players in the Market.

The market is driven by the growing demand for molecular diagnostics and serological assays in patient management, public health interventions, surveillance, outbreak response, disease prevention strategies, risk monitoring, and pandemic prevention. The market landscape depends on the Next generation sequencing, arthropod borne viral diseases, point of care testing, healthcare institutions, and public health laboratory. Arthropod-borne viruses such as Dengue fever, Zika virus infection, West Nile fever, Powassan, and Yellow fever are the major targets of diagnostic tests. Climate change is a significant factor influencing the spread of these diseases, further driving the need for surveillance and testing. In conclusion, the Market is expected to grow at a steady pace due to the increasing burden of arbovirus-related diseases and the need for accurate and timely diagnosis. The market is driven by the growing demand for molecular diagnostics and serological assays in patient management, public health interventions, surveillance, outbreak response, disease prevention strategies, risk monitoring, and pandemic prevention.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2023 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies